ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

StartupsDealStreetAsiaabout 2 hours ago

AusperBio secures $120m Series C

1 min read

AusperBio secured $120 million in Series C funding to advance chronic hepatitis B therapies. The biopharma firm will use the capital to progress its clinical pipeline. The financing supports development of treatments targeting the chronic liver infection.

Level

Hype check

Tap to vote and see what everyone thinks.

#ausperbio #biopharma #hepatitis b

Read full story